Related Experiment Videos
Protein kinase C--a novel target for rational anti-cancer drug design?
Anti-Cancer Drug Design
|August 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Assessment of viability of hepatocytes in suspension using the MTT assay.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Modulation of gene transcription by natural products--a viable anticancer strategy.
Current pharmaceutical design·2007
Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma.
European journal of cancer (Oxford, England : 1990)·2006
Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents?
Journal of chemotherapy (Florence, Italy)·2005
Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention?
European journal of cancer (Oxford, England : 1990)·2004
Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Anti-cancer drug design·2002
The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
Anti-cancer drug design·2002
Photokilling of cultured tumour cells by the porphyrin derivative CF3.
Anti-cancer drug design·2002
Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Anti-cancer drug design·2002
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
Anti-cancer drug design·2002
Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.
medRxiv : the preprint server for health sciences·2026
The therapy-conditioned host: a state-transition framework for second primary cancer evolution.
Frontiers in oncology·2026